Market Exclusive

Analyst Activity – Argus Reiterates Buy on Bristol-Myers Squibb (NYSE:BMY)

Analyst Ratings For Bristol-Myers Squibb (NYSE:BMY)

Today, Argus reiterated its Buy rating on Bristol-Myers Squibb (NYSE:BMY) with a price target of $66.43.

Some recent analyst ratings include

Dividend information for Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 2.41% and an average dividend growth of 2.70% based on a 3 Year Average..

Dividend History for Bristol-Myers Squibb (NYSE:BMY)

Recent Insider Trading Activity For Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 71.49%.

Recent Trading Activity for Bristol-Myers Squibb (NYSE:BMY)
Shares of Bristol-Myers Squibb closed the previous trading session at with shares trading hands.

Exit mobile version